6621 TWO Week ended 14 Aug 2026

Weekly Investor Report

UniPharma Co., Ltd. · Healthcare · Drug Manufacturers - Specialty & Generic

Open interactive chart View report data
Latest close 11.65 TWD
7.4% latest week
Weekly setup

Mixed setup

The weekly trend is not active. Price is -4.3% below the Trend Line and sits at 19.4% of its 52-week range. The latest completed week returned 7.4%, after a 3.1% four-week move.

Setup score 28 out of 100
Latest Close 11.65 TWD 14 Aug 2026
1W Return 7.4% latest completed week
4W Return 3.1% short-term follow-through
12W Return -3.3% quarterly tape
Trend Breadth 15.4% 8 of 52 weeks active
Volume Ratio 1.0x vs 13-week average
What is working
  • No strong opportunity cluster is confirmed yet; monitor trend and activity pressure.
What could go wrong
  • The trend backdrop is inactive, so price action has not confirmed a constructive regime.
  • Price is below the Trend Line, which keeps downside pressure in focus.
  • Price is below Fair Value, so the market is still discounting the latest tape.
  • Activity pressure is negative, which weakens the current setup.
What to watch next
  • Trend Line remains the key weekly regime level.
  • Activity pressure is the gauge to monitor for confirmation or fade.
  • A volume ratio above 1.5x would show stronger participation in the next move.
Price follow-through 7.4% Latest completed week; four-week move 3.1%. Indicator stack 8/31 Trend and activity pressure are weighted against the latest 12-week confirmation window. Trend backdrop Active The trend backdrop defines the current weekly regime. Patient Capital Quiet Activity-pressure buy-signal status for institutional accumulation timing. Next-Week Expectancy Negative 34.41% Historical one-week expectancy contributes to the evidence score when direction is confirmed.
01 · Price action

Where price is—and whether the trend supports it

The weekly trend is not active. Price is -4.3% below the Trend Line and sits at 19.4% of its 52-week range. The latest completed week returned 7.4%, after a 3.1% four-week move.

Study the full chart

52-week price path

Price vs Trend Line and Fair Value
Price Trend Line Fair Value
02 · Volume and demand

Is real participation confirming the move?

Latest weekly volume is 1.0x the 13-week average. Participation is around or above normal and provides reasonable confirmation.

26-week volume confirmation

Bar height shows volume; colour shows the weekly price direction
13 Feb 27 Feb 6 Mar 13 Mar 20 Mar 27 Mar 3 Apr 10 Apr 17 Apr 24 Apr 1 May 8 May 15 May 22 May 29 May 5 Jun 12 Jun 19 Jun 26 Jun 3 Jul 10 Jul 17 Jul 24 Jul 31 Jul 7 Aug 14 Aug
Up week Down week
Demand beneath price

Activity pressure and institutional-style signals

These indicators assess whether participation is improving beneath the headline price move. They are supporting evidence, not proof of institutional buying.

Activity pressure path

Latest 0.0112-week average 0.17

12-week confirmation

Trend active0/12Active trend-backdrop weeks in the latest 12-week window.
Positive pressure0/12Weeks with constructive activity pressure in the latest 12-week window.
Positive leadership0/12Weeks with positive relative leadership in the latest 12-week window.
Activity pressure0.01Current proprietary activity-pressure read.
Buy signals0Accumulation signal count in the latest 12 weeks.
Reversal markers0No reversal markers

No recent accumulation markers. No reversal markers.

03 · Momentum and leadership

Is performance persistent—and is the stock leading?

Performance is 3.1% over four weeks, -3.3% over 12 weeks, and -9.0% over one year. The current trend has remained active for 0 consecutive weeks.

Performance by holding period

1W7.4%
4W3.1%
12W-3.3%
26W-4.1%
52W-9.0%
Active trend streak0 weeks
Active weeks in one year8
Trend breadth15.4%

Activity pressure vs relative leadership

Activity pressureRelative leadership
Pressure-1.07Latest activity-pressure read.
Pressure change4.0%Four-week change in activity pressure.
Leadership-33.07Latest relative-leadership reading.
RS change3.7%Four-week change in relative leadership.
04 · Fundamentals and valuation

What investors are paying for—and the quality behind it

A published fundamentals and factor snapshot is not available for this company.

Open full factor analysis

No published fundamental snapshot is available for this company.

05 · Ownership, options, and sentiment

What other market participants are doing

Options, insider transactions, market sentiment, and activity-pressure signals can confirm or challenge the price story. None should be used alone.

Insider activity-

No recent insider transactions are stored for this company.

News sentiment-

No current sentiment snapshot is stored.

Patient CapitalQuiet

Activity-pressure buy-signal evidence highlights potential institutional accumulation windows.

No recent buy signal
06 · Catalysts and risk

What can move the shares—and how volatile the path has been

Event timing, options-implied movement, drawdown, and weekly return distribution frame the risk around the current setup.

Next earnings-No event is currently stored.
Options expected move-Nearest-chain priced movement where available.
52-week drawdown-27.2%Distance below the 52-week high.
13-week volatility2.9%Standard deviation of weekly returns.

Weekly gains and losses

Latest 26 completed weeks

Each bar is one week. Gains rise above the zero line; losses fall below it. Taller bars mean a larger weekly move.

Weeks higher10 of 2614 weeks finished lower.
Best week+9.1%Week of 24 Apr.
Worst week-12.6%Week of 1 May.
Latest week+7.4%Week of 14 Aug.

Shape of recent returns

Strong gains4
Modest gains6
Flat weeks2
Modest losses13
Sharp losses1
Recent vol2.9%13-week weekly-return volatility.
Base vol3.6%52-week weekly-return volatility.
Up/down split18/31Count of positive and negative weeks in the 52-week window.
Average skew3.6% / -2.3%Average positive week versus average negative week.
07 · Sector and peer context

Is this stock leading—or simply moving with its group?

Sector and industry breadth distinguish company-specific strength from a broad group move.

08 · Evidence and weekly data

The underlying research record

Every top-level statement above should be traceable to a stored market, fundamental, event, or positioning observation.

Weekly tape23/100

Trend, activity pressure, participation, and risk combine to a 23/100 tape read.

 Indicator analysis9/100

Latest 12-week confirmation: trend 0/12, activity pressure 0/12, relative leadership 0/12.

Activity pressure 0.01; No reversal markers Next-Week ExpectancyNegative 34.41%

Next-week expectancy is negative with a 34.41% historical one-week setup read.

Adds short-term historical context without overriding trend, activity, or relative leadership. Factors50/100

No published factor snapshot is available yet.

 Patient CapitalQuiet

Activity-pressure buy-signal evidence highlights potential institutional accumulation windows.

No recent buy signal Sentiment50/100

No sentiment snapshot is stored yet.

 Insiders50/100

No recent insider transaction evidence is stored.

 Earnings50/100

No stored earnings event is currently attached to this ticker.
WeekCloseReturnTrend LineFair ValuePressureLeadershipVolumeTrend
14 Aug 202611.65 TWD7.4%12.18 TWD13.79 TWD-1.07-33.07276.0KOff
7 Aug 202610.85 TWD0.0%12.19 TWD13.83 TWD-1.26-36.3394.9KOff
31 Jul 202610.85 TWD-3.6%12.23 TWD13.88 TWD-1.10-35.59156.0KOff
24 Jul 202611.25 TWD-0.4%12.27 TWD13.92 TWD-1.02-35.07129.2KOff
17 Jul 202611.30 TWD-2.6%12.31 TWD13.98 TWD-1.11-34.34777.1KOff
10 Jul 202611.60 TWD3.1%12.37 TWD14.03 TWD-1.24-37.63143.1KOff
3 Jul 202611.25 TWD1.4%12.38 TWD14.09 TWD-1.26-42.32206.4KOff
26 Jun 202611.10 TWD-2.2%12.41 TWD14.14 TWD-1.22-41.30318.7KOff
19 Jun 202611.35 TWD-3.4%12.45 TWD14.19 TWD-1.09-43.41198.5KOff
12 Jun 202611.75 TWD0.9%12.48 TWD14.23 TWD-0.96-39.39231.9KOff
5 Jun 202611.65 TWD-2.1%12.50 TWD14.27 TWD-0.88-42.10435.0KOff
29 May 202611.90 TWD-1.2%12.51 TWD14.31 TWD-0.69-41.44475.9KOff
22 May 202612.05 TWD-0.8%12.52 TWD14.34 TWD-0.47-38.26248.9KOff
15 May 202612.15 TWD-0.8%12.52 TWD14.37 TWD0.17-37.08388.6KOff
How to use this report

This is a completed-week research summary. It explains the available evidence and its conflicts; it does not predict a guaranteed outcome or replace your own risk assessment. Fundamental figures may refer to an earlier financial reporting period, which is shown above.

Evidence context